Sodium Glucose Co-transporter-2 Inhibitors in Patients with Systemic Sclerosis with or without Heart Failure. Augusto SN Jr, Kaelber DC, Chatterjee S, Tang WHW, et al. Am J Med 2025 Aug 12:S0002-9343(25)00529-7. doi: 10.1016/j.amjmed.2025.

Read + Share

Amedeo Smart

Independent Medical Education

Augusto SN Jr, Kaelber DC, Chatterjee S, Tang WHW, et al. Sodium Glucose Co-transporter-2 Inhibitors in Patients with Systemic Sclerosis with or without Heart Failure. Am J Med 2025 Aug 12:S0002-9343(25)00529-7. doi: 10.1016/j.amjmed.2025.
PMID: 40812492